​

Prof. Amir Shlomai graduated from the Hebrew University-Hadassah Medical School in 2001/2002. After a year of rotating internship at Hadassah hospital in Jerusalem, he moved to Professor Yosef Shaul’s laboratory at the Weizmann Institute of Science where he studies the molecular biology of hepatitis B virus (HBV) for several years and earned both Master (with distinction) and Ph.D. degrees. Prof. Shlomai was the first to show that the then newly-discovered RNA interference phenomenon could be used as an efficient anti-HBV tool. In addition, Prof. Shlomai discovered that HBV expression is significantly influenced by metabolic and nutritional cues that mediate major hepatic metabolic processes, thereby acting as a “metabolovirus”. During the following years, Prof. Shlomai completed his residencies in both Internal Medicine and Gastroenterology and Liver diseases at Tel-Aviv Sourasky Medical Center, Israel, where he also headed his own research group. In July 2012 Prof. Shlomai joined the lab of Professor Charles M. Rice at the Rockefeller University and appointed an Instructor in Clinical Investigation as a part of the Clinical Scholar program. At Professor Rice’s lab, his research focused on developing novel tissue culture systems for studying hepatitis B virus biology and on exploiting the CRISPR/Cas9 system as an anti-HBV strategy. After two years at Rockefeller, Prof. Shlomai has returned to Israel and joined the Rabin Medical Center (Beilinson Campus) as the head of the hepatitis service and from October 2015 he is the head of the Department of Medicine D and the Laboratory of Liver Research in this hospital.

His current research interests focus on the role of HBV infection in liver metabolism, non-invasive tools to assess MASLD, and MASLD phenotyping. Prof. Shlomai is Israeli board-certified in Internal Medicine and in Gastroenterology and Liver Diseases. He is also ECFMG certified and is a faculty member at Associate Professor degree of the Sackler Faculty of Medicine, Tel-Aviv University. He is an adjunct professor at the Weizmann Institute of Science and the Vice Dean for clinical studies at the Weizmann MD/PhD program. Prof. Shlomai served as the president of the Israeli Association for the Study of the Liver (2022-25) and is currently a member of the national council of gastroenterology and nutrition.